Hana Pharm Co., Ltd. (KRX:293480)
South Korea · Delayed Price · Currency is KRW 8,670.00
+10.00 (0.12%)
At close: Aug 3, 2026
Hana Pharm Market Cap
Hana Pharm has a market cap or net worth of 154.09 billion as of August 3, 2026. Its market cap has decreased by -25.96% in one year.
Market Cap
154.09B
Enterprise Value
n/a
Revenue
139.33B
Ranking
n/a
PE Ratio
3.87
Stock Price
8,670.00
ChartMarket Cap Chart
Since October 2, 2018, Hana Pharm's market cap has decreased from 537.03B to 154.09B, a decrease of -71.31%. That is a compound annual growth rate of -14.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 154.09B | -22.73% |
| Dec 30, 2025 | 199.41B | 2.94% |
| Dec 30, 2024 | 193.73B | -21.86% |
| Dec 28, 2023 | 247.93B | -23.56% |
| Dec 29, 2022 | 324.36B | -9.43% |
| Dec 30, 2021 | 358.12B | -14.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dong Sung Bio Pharm.Co.,Ltd. | 173.31B |
| JW Lifescience | 172.50B |
| FutureChem Co.,Ltd | 170.86B |
| BNC KOREA | 162.10B |
| Daewon Pharmaceutical | 158.39B |
| Daihan Pharmaceutical | 155.53B |
| Ilyang Pharmaceutical Co.,Ltd | 150.21B |
| Hyundai Pharmaceutical | 148.35B |